PZ Cussons plc (LON:PZC)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 331.24M +9.7% |
| Revenue (ttm) | 533.80M +6.7% |
| Net Income | -4.90M |
| EPS | -0.01 |
| Shares Out | 420.35M |
| PE Ratio | n/a |
| Forward PE | 10.81 |
| Dividend | 0.04 (4.57%) |
| Ex-Dividend Date | Mar 5, 2026 |
| Volume | n/a |
| Average Volume | 574,022 |
| Open | 79.90 |
| Previous Close | 78.80 |
| Day's Range | 77.20 - 82.60 |
| 52-Week Range | 65.09 - 92.10 |
| Beta | 0.50 |
| RSI | 54.04 |
| Earnings Date | Aug 6, 2026 |
About PZ Cussons
PZ Cussons plc manufactures, distributes, markets, and sells baby, beauty, and hygiene products in Europe, the Asia Pacific, the Americas, and Africa. The company offers toiletries, pharmaceuticals, electrical goods, edible oils, fats and spreads, nutritional products, shampoos, body washes, toothpastes, toothbrushes, skin and hair care products, food pouches, cereals, snacks, flavors, and fragrances; beauty soaps, lotions, wipes, creams, shower gels, foam-bursts, bar soaps, deodorants, bath infusions, handwashes, and conditioners; ointments; d... [Read more]
Financial Performance
In fiscal year 2025, PZ Cussons's revenue was 513.80 million, a decrease of -2.67% compared to the previous year's 527.90 million. Losses were -5.80 million, -89.82% less than in 2024.
Financial StatementsNews
PZ Cussons Transcript: CMD 2026
A renewed strategy focuses on core categories and lead markets, driving mid-single-digit revenue growth and double-digit shareholder returns through innovation, local insights, and disciplined capital allocation. Guardrails and operational improvements mitigate risks, while targeted M&A and market-specific strategies fuel sustainable growth.
PZ Cussons Earnings Call Transcript: H1 2026
Strong first-half results with 9.5% like-for-like revenue growth and improved margins, driven by broad-based gains across regions and brands. Balance sheet strengthened by asset disposals, and full-year profit guidance raised, though H2 will see higher marketing spend and lower profit.
PZ Cussons Earnings Call Transcript: H2 2025
Revenue declined due to FX, but like-for-like growth was 8% with strong UK and Indonesia performance. Cost savings, asset sales, and the Wilmar JV exit will reduce leverage and fund brand investment. St. Tropez is retained with a new US strategy and leadership.
PZ Cussons Earnings Call Transcript: H1 2025
Solid like-for-like revenue growth of 7.1% was achieved, with strong performance in the U.K., Indonesia, and ANZ, despite FX headwinds from Naira devaluation. Profitability improved in key markets, and the business remains on track to meet full-year profit expectations.
PZ Cussons Transcript: AGM 2024
The AGM addressed the impact of naira devaluation, strategic portfolio focus, and operational progress in key markets. All resolutions were passed, with ongoing efforts to reduce risk and improve shareholder value. Dividend policy and business disposals remain under review.
PZ Cussons Earnings Call Transcript: H2 2024
Operational progress and profit in line with guidance were achieved despite a 70% naira devaluation, with strong UK and ANZ growth offsetting Africa's currency-driven decline. Strategic actions include selling St. Tropez and exploring options for the Africa business.